Trial
NCT01194869
Preoperative Trial of Sorafenib in Combination With Cisplatin Followed by Paclitaxel for Early Stage Breast Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Emory University
Collaborators
Amgen; Bayer
Condition
Breast Cancer
Intervention
Sorafenib
Why stopped
Slow accrual, availability of other clinical options
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-10-18